Case Study: Aytu BioPharma achieves 12 earned media placements and 315M+ impressions with Interdependence

Aytu BioPharma earns 315 million media impressions in 4 months with Interdependence

Aytu BioPharma, a pharmaceutical company, faced low market visibility for its ADHD medication, Adzenys XR-ODT, during a widespread Adderall shortage. Their challenge was to quickly raise awareness of their product as an available solution for patients struggling to source their medication. They engaged the vendor, Interdependence, to help drive media coverage for this goal.

Interdependence implemented a targeted media outreach campaign, leveraging timely pitches, expert commentary, and proprietary technology to insert the brand into trending news. The solution secured 12 earned media placements, resulting in more than 315 million media impressions. This effectively reached key audiences and included six brand-building interviews, successfully introducing Adzenys XR-ODT as a bioequivalent alternative.

Aytu BioPharma